Volume | 29 795 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,75 | Bas Haut |
|||||
Minimum Bas | 0,73 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,739 | 0,73 | 0,75 | 0,73 | 0,7521 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
146 | 29 795 | US$ 0,7360416 | US$ 21 930 | - | 0,50 - 3,59 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:31:46 | 10 | US$ 0,721 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
1,83M | 2,44M | - | 0 | -10,83M | -4,43 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Phio Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
28/5/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
20/5/2024 | 23:03 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
20/5/2024 | 22:59 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
17/5/2024 | 22:45 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
17/5/2024 | 15:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
17/5/2024 | 15:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Secures New Investor |
17/5/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
16/5/2024 | 14:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Presents This Week at the Society for.. |
15/5/2024 | 19:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Announces Completion of Dosing in First.. |
09/5/2024 | 23:25 | GlobeNewswire Inc. | Phio Pharmaceuticals Reports Q1 2024 Results and Provides.. |
09/5/2024 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 23:20 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Phio Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Phio Pharmaceuticals Corporation
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,768 | 0,78 | 0,73 | 0,7639485 | 16 155 | -0,038 | -4,95% |
1 mois | 0,81 | 0,948899 | 0,6512 | 0,7966929 | 105 785 | -0,08 | -9,88% |
3 mois | 0,90 | 1,11 | 0,604849 | 0,8323891 | 288 644 | -0,17 | -18,89% |
6 mois | 1,02 | 2,09 | 0,50 | 1,14 | 527 499 | -0,29 | -28,43% |
1 an | 3,59 | 3,59 | 0,50 | 1,82 | 521 187 | -2,86 | -79,67% |
3 ans | 26,64 | 29,64 | 0,50 | 14,53 | 670 998 | -25,91 | -97,26% |
5 ans | 5,256 | 130,20 | 0,50 | 19,11 | 724 608 | -4,53 | -86,11% |